Does Wall Street Rate Tricida Inc. (TCDA) Shares A Sell?

0
3

As of Wednesday close, Tricida Inc.’s (NASDAQ:TCDA) stock was down -$0.02, moving down -7.08 percent to $0.19. The average number of shares traded per day over the past five days has been 11,655,521 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0578 fall in that time frame. In the last twenty days, the average volume was 15,532,845, while in the previous 50 days, it was 10,262,021.

Since last month, TCDA stock retreated -65.05%. Shares of the company fell to $0.1925 on 11/23/22, the lowest level in the past month. A 52-week high of $13.85 was reached on 08/24/22 after having rallying from a 52-week low of $0.21. Since the beginning of this year, TCDA’s stock price has dropped by -97.98% or -$9.3670, and marked a new high 11 times. However, the stock has declined by -98.61% since its 52-week high.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


TCDA stock investors should be aware that Tricida Inc. (TCDA) stock had its last reported insider trading activity 4 days ago on Nov 21. Alpern Robert J, the Director of the company, disposed of 27,584 shares for $0.23 on Nov 21. It resulted in a $6,344 divestment by the insider. Venrock Healthcare Capital Par sold 2,367,174 shares at an average price of $0.46 on Oct 26. The insider now owns 3,751,406 shares following the transaction. On Oct 25, 10% Owner Venrock Healthcare Capital Par sold 1,970,418 shares at $0.57 apiece. The transaction was valued at $1,123,138.

Financial Health

In the three months ended September 29, Tricida Inc.’s quick ratio stood at 4.90, while its current ratio was 4.90, showing that the company is able to pay off its debt. Based on annual data, TCDA earned $17.6 million in gross profit and brought in $152.95 million in revenue.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Tricida Inc. to report -$0.54 quarterly earnings, the actual figure was -$0.44 per share, beating the consensus estimate by 18.50%. During the quarter, the company generated -$24.01 million in EBITDA. The liabilities of Tricida Inc. were 229.98 million at the end of its most recent quarter ended September 29, and its total debt was $208.0 million. The value of shareholders’ equity is $58.03 million.

Technical Picture

This quick technical analysis looks at Tricida Inc.’s (TCDA) price momentum. With a historical volatility rate of 107.17%, the RSI 9-day stood at 15.62% on 23 November.

With respect to its five-day moving average, the current Tricida Inc. price is down by -23.05% percent or -$0.0578. At present, TCDA shares trade -58.67% below its 20-day simple moving average and -98.09% percent below its 100-day simple moving average. However, the stock is currently trading approximately -98.18% below its SMA50 and -98.14% below its SMA200.

Stochastic coefficient K was 2.58% and Stochastic coefficient D was 9.28%, while ATR was 0.2045. Given the Stochastic reading of 0.38% for the 14-day period, the RSI (14) reading has been calculated as 19.49%. As of today, the MACD Oscillator reading stands at -0.0315, while the 14-day reading stands at -0.0381.

Analyst Ratings

Goldman launched its rating on Tricida Inc. (NASDAQ: TCDA) to a Buy in a note to investors on April 13, 2022. Tricida Inc. (TCDA) has been rated Underweight by analysts. According to 1 brokerage firm, TCDA is a sell, and 2 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Tricida Inc. stock as buy, with 0 recommending it as overweight.

With a median target price of $20.00, the current consensus forecast for the stock is $20.00 – $20.00. Based on these forecasts, analysts predict Tricida Inc. (TCDA) will achieve an average price target of $20.00.

LEAVE A REPLY

Please enter your comment!
Please enter your name here